Public Company News

Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30

-          First participants with obesity or overweight with at least one w eight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of small molecule GLP-1  receptor agonist ASC30. -          Ultra-long-acting SQ depot for...

2025-07-28 08:15 2029

Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2025 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a positive prof...

2025-07-28 08:11 2161

Consecutive Victories by TGE and AMTD Against IP Infringements

PARIS and NEW YORK and SINGAPORE, July 25, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD" or the "Group"), alongside The Generation Essentials Group ("TGE"), a subsidiary of the Group under AMTD Digital, jointly announce that as a global owner of fashion magazines published under "L'OFFICIEL AMTD" ...

2025-07-25 22:58 5909

TROOPS, Inc. (NASDAQ: TROO) Intends to Bolster Shareholder Value with Strategic Stock Repurchase

HONG KONG, July 25, 2025 /PRNewswire/ -- TROOPS, Inc. (NASDAQ: TROO) ("TROOPS" or the "Company") today announced that the Company has initiated its stock repurchasing plan by entering into a stock repurchase agreement (the "Stock Repurchase Agreement") with an existing shareholder (the "Sharehold...

2025-07-25 20:30 3786

Nature's Miracle Holding Inc. ("NMHI") Management and a Lender Invested $1.69 Million in NMHI Shares through Liability and Debt Conversion

ONTARIO, Calif., July 25, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology today announced that certain members of the Company's management team including CEO, President and CFO and a Lender agreed to co...

2025-07-25 20:30 3270

Amcor announces registered exchange offers

ZURICH, July 25, 2025 /PRNewswire/ -- Amcor plc ("Amcor") (NYSE: AMCR, ASX: AMC) today announced the commencement of offers (the "exchange offers") by Amcor Flexibles North America, Inc., Amcor's wholly-owned subsidiary (the "Issuer") and the guarantors, including Amcor (the "Guarantors"), to exc...

2025-07-25 20:12 3123

Delta Inaugurates Smart Manufacturing Innovation Center

One-Stop Platform in Taiwan for Equipment Validation and Talent Training to Accelerate AI-based Manufacturing Worldwide TAIPEI, July 25, 2025 /PRNewswire/ -- Delta, a global leader in power management and smart green solutions, today inaugurated inTaiwan its Smart Manufacturing Innovation Center...

2025-07-25 17:39 3251

Pony.ai Kicks Off 24/7 Robotaxi Operation in Major Chinese Cities

GUANGZHOU, China, July 25, 2025 /PRNewswire/ -- Pony.ai (NASDAQ: PONY), a global leader in autonomous driving technology, today starts around-the-clock Robotaxi operation in the Chinese megacities ofGuangzhou and Shenzhen, two of southernChina's dynamic economic engines. This move marks a major s...

2025-07-25 16:30 2490

Sohu.com to Report Second Quarter 2025 Financial Results on August 4, 2025

BEIJING, July 25, 2025 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), a leading Chinese online media platform and game business group, will report its second quarter 2025 unaudited financial results onMonday, August 4, 2025, before U.S. market hours. Sohu's management team will host a confer...

2025-07-25 13:00 2245

Angel Yeast Showcases Innovative Yeast Protein at 2025 IFT FIRST in Chicago

CHICAGO, July 24, 2025 /PRNewswire/ -- The 2025 IFT FIRST (Food Improved by Research, Science, and Technology), one of the world's largest food science and innovation expos, recently took place fromJuly 13 to 16 in Chicago. At the expo, Angel Yeast (SHA:600298) showcase...

2025-07-24 21:00 2483

Pop Culture Strategy Partners with Macau Platinum to Invest Heavily in Creating a New Benchmark for Global Distribution of Chinese Short Dramas

XIAMEN, China, July 24, 2025 /PRNewswire/ -- Leading integrated entertainment group Pop Culture Group Co., Ltd ("CPOP" or the "Company") (Nasdaq: CPOP) recently announced a deep strategic cooperation with Macau Platinum, a professional distributor of short dramas. The Company will invest core re...

2025-07-24 20:45 2689

Yiren Digital Releases its 2024 ESG Report: AI Deepens Sustainable Practices Across the Board

BEIJING, July 24, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services in Asia, today announced the release of its annual ESG report for the year ended December 31, 2024. ...

2025-07-24 20:37 2566

Intelligent Living Application Group Inc. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

HONG KONG, July 24, 2025 /PRNewswire/ -- Intelligent Living Application Group Inc. (NASDAQ: ILAG) ("Intelligent Living" or the "Company"), a premium lockset manufacturer inHong Kong, announced today that, on July 23, 2025, the Company received a written notification from the NASDAQ Stock Market L...

2025-07-24 20:00 2365

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

BELLEVUE, Wash. and SEOUL, South Korea, July 24, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced it has signed a term sheet ("Term Sheet") with Woori IO Co., Ltd. ("WORIO"), a South Korean medical de...

2025-07-24 19:30 2268

Yum China Announces Disclosure under Hong Kong Stock Exchange Rules in Relation to a Possible Quarterly Dividend

SHANGHAI, July 24, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced, in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "HKEX") which require advance notice of boar...

2025-07-24 17:38 2279

Weibo Corporation to Report Second Quarter 2025 Financial Results on August 14, 2025

BEIJING, July 24, 2025 /PRNewswire/ -- Weibo Corporation (Nasdaq: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the second quarter 2025 before the U.S. market opens onThursday, August 14, 2025. Follow...

2025-07-24 17:00 1957

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

HONG KONG, July 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a first-in-class PD-1/VEGF bispecific antibody dev...

2025-07-24 09:14 1454

SK hynix Announces 2Q25 Financial Results

* Reports revenues of 22.232 trillion won, operating profit of 9.2129 trillion won, net profit of 6.9962 trillion won * Both revenues, operating profit at all-time highs following brisk sales of AI memory * Company to provide best-in-class AI products timely for customer satisfaction, marke...

2025-07-24 06:47 2092

Health In Tech to Host Independent InsurTech Summit in Davos During World Economic Forum Week 2026

STUART, Fla., July 23, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce it will host an exclusive half-day Summit onJanuary 20, 2026, from  11:30 a.m. to 4:30 p.m. (CET) at the prestigious Belvedere Hotel in...

2025-07-23 21:15 1934

HBM9378/WIN378, a Long-Acting, Fully Human Anti-TSLP Antibody, Enters Global Phase 2 POLARIS Trial for Asthma

* Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of HBM9378/WIN378 in patients with asthma, with an initial data readout expected in mid-2026 * HBM9378/WIN378 has the potential to be the first-to-market long-acting anti-TSLP antibody with twice-yearly dosing for asthma ...

2025-07-23 20:36 2195
1 ... 54555657585960 ... 777

Week's Top Stories